BackCannara Biotech Overview

Cannara Biotech Total Liabilities

Track Cannara Biotech's total liabilities ($69M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$68.64M
↓ 3.99% YoYΔ $-2.85M vs prior year quarter

Peer trimmed avg / median

Loading

Cannara Biotech Total Liabilities History

Loading

Cannara Biotech vs. peers: Total Liabilities Comparison

Loading

Cannara Biotech Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cannara Biotech (LOVFF) FAQ

The latest total liabilities for LOVFF is $69M as of May 2026. That compares with $71M in the prior-year period — down 4.0% year over year. Investors often review this figure alongside Cannara Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, LOVFF's total liabilities moved from $71M to $69M — a 4.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cannara Biotech's operating scale or balance-sheet position.

A total liabilities figure of $69M for LOVFF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LOVFF's total liabilities ($69M), review year-over-year change from $71M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers